Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),Neurology
Reference46 articles.
1. Mena R, Edwards P, Pérez-Olvera O, Wischik CM. Monitoring pathological assembly of tau and β-amyloid proteins in Alzheimer's disease. Acta Neuropathol. 1995;89:50–6.
2. An TH, Termont A, Merchiers P, Schilling S, Demuth HU, Scrocchi L, et al. Pathological hallmarks, clinical parallels, and value for drug testing in Alzheimer’s disease of the APP[V717I] London transgenic mouse model. Int J Alzheimer Dis. 2010;2010:417314.
3. Braak J, Tredici KD. The preclinical phase of the pathological process underlying sporadic Alzheimer's disease. Brain. 2015;138:2814–33.
4. He Z, Guo JL, McBride JD, Narasimhan S, Kim H, Changolkar L, et al. Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat Med. 2018;24:29–38.
5. Nordberg A, Rinn JO, Kadir A, Långström B. The use of PET in Alzheimer disease. Nature Rev Neurol. 2010;6:78–877.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献